Jingxin C. Mo

35 Stirling Highway
Crawley, WA 6009, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications

Potential role of formononetin as a novel natural agent in Alzheimer's disease and osteoporosis comorbidity.

Potential role of formononetin as a novel natural agent in Alzheimer's disease and osteoporosis comorbidity.

Journal: Journal of Alzheimer's disease : JAD
Published: January 19, 2025

A ROS-responsive, aptamer-targeted graphene oxide nanocomposite for site-specific glutathione release in cerebral ischemia-reperfusion injury.

A ROS-responsive, aptamer-targeted graphene oxide nanocomposite for site-specific glutathione release in cerebral ischemia-reperfusion injury.

Journal: Frontiers in pharmacology
Published: December 12, 2024

Mogroside V ameliorates astrocyte inflammation induced by cerebral ischemia through suppressing TLR4/TRADD pathway.

Mogroside V ameliorates astrocyte inflammation induced by cerebral ischemia through suppressing TLR4/TRADD pathway.

Journal: International immunopharmacology
Published: September 29, 2024

Correction: Benington et al. In Vitro Assessment of Wound-Healing Efficacy of Stabilized Basic Fibroblast Growth Factor (FGF-2) Solutions. Pharmaceuticals 2024, 17, 247.

Correction: Benington et al. In Vitro Assessment of Wound-Healing Efficacy of Stabilized Basic Fibroblast Growth Factor (FGF-2) Solutions. Pharmaceuticals 2024, 17, 247.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 28, 2024

Corrigendum: Double cross-linked graphene oxide hydrogel for promoting healing of diabetic ulcers.

Corrigendum: Double cross-linked graphene oxide hydrogel for promoting healing of diabetic ulcers.

Journal: Frontiers in chemistry
Published: February 29, 2024

In Vitro Assessment of Wound-Healing Efficacy of Stabilized Basic Fibroblast Growth Factor (FGF-2) Solutions.

In Vitro Assessment of Wound-Healing Efficacy of Stabilized Basic Fibroblast Growth Factor (FGF-2) Solutions.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: January 16, 2024

Advancing stroke therapy: the potential of MOF-based nanozymes in biomedical applications.

Advancing stroke therapy: the potential of MOF-based nanozymes in biomedical applications.

Journal: Frontiers in bioengineering and biotechnology
Published: December 30, 2023

Double cross-linked graphene oxide hydrogel for promoting healing of diabetic ulcers.

Double cross-linked graphene oxide hydrogel for promoting healing of diabetic ulcers.

Journal: Frontiers in chemistry
Published: December 14, 2023

GSK-J1-loaded, hyaluronic acid-decorated metal-organic frameworks for the treatment of ovarian cancer.

GSK-J1-loaded, hyaluronic acid-decorated metal-organic frameworks for the treatment of ovarian cancer.

Journal: Frontiers in pharmacology
Published: August 20, 2022

Intranasal administration of dauricine loaded on graphene oxide: multi-target therapy for Alzheimer's disease.

Intranasal administration of dauricine loaded on graphene oxide: multi-target therapy for Alzheimer's disease.

Journal: Drug delivery
Published: March 17, 2021

Calixarene-mediated assembly of water-soluble C60-attached ultrathin graphite hybrids for efficient activation of reactive oxygen species to treat neuroblastoma cells.

Calixarene-mediated assembly of water-soluble C60-attached ultrathin graphite hybrids for efficient activation of reactive oxygen species to treat neuroblastoma cells.

Journal: Chemical communications (Cambridge, England)
Published: June 02, 2020

Metal ion-responsive nanocarrier derived from phosphonated calix[4]arenes for delivering dauricine specifically to sites of brain injury in a mouse model of intracerebral hemorrhage.

Metal ion-responsive nanocarrier derived from phosphonated calix[4]arenes for delivering dauricine specifically to sites of brain injury in a mouse model of intracerebral hemorrhage.

Journal: Journal of nanobiotechnology
Published: November 19, 2019
Showing 1-12 of 29

Last Updated: 09/26/2026